Neurol. praxi. 2018;19(5):359-364 | DOI: 10.36290/neu.2018.118

When to consider inflammatory rheumatic disease in the differential diagnosis of back pain?

MUDr. Olga Šléglová
Klinika revmatologie 1. LF UK a Revmatologický ústav, Praha

Aim: To highlight the need for early diagnosis of inflammatory rheumatic causes of back pain that, due to their rare occurrence,tend to be overlooked easily in patients with back pain.Summary: The group of inflammatory rheumatic diseases of the back (spondyloarthritides /SpA/) include autoimmune inflammatorydiseases wherein the inflammation affects the axial skeleton, root joints, and peripheral joints, predominantly in the lowerlimbs. The most common disease of the SpA group is ankylosing spondylitis (Bechterew’s disease). The diagnosis of ankylosingspondylitis has been based on the 1984 modified New York criteria which require radiographic confirmation of injury to thesacroiliac joints. The author aims to highlight in the article that the use of novel diagnostic methods has fundamentally changedthe approach to this disease, and presents an overview of the current classification criteria that allow for detection of the diseaseprior to developing permanent structural changes.

Conclusion: Early diagnosis allows for a rapid commencement of adequate treatment that can significantly affect the furthercourse of the disease.

Keywords: back pain, axial spondyloarthritis, ankylosing spondylitis

Published: October 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šléglová O. When to consider inflammatory rheumatic disease in the differential diagnosis of back pain? Neurol. praxi. 2018;19(5):359-364. doi: 10.36290/neu.2018.118.
Download citation

LMm_References

  1. Barsa P, Häckel M. Systém "červených praporků" v diagnostice a terapii bolestí zad. Bolest 2004; (Suppl. 2): 15-19.
  2. Bednařík J, Kadaňka Z. Bolesti v zádech. In: Rokyta R. a kol. Bolest. Tigis, spol. s. r. o., Praha 2006: 485-507.
  3. Coates LC, Kavanaungh A, Mease PJ, Soriano EP, Laura Acosta-Felquer M, Armstrong AW, Bautista-Molano W, Boehncke WH, Campbell W, Cauli A, Espinoza LR, FitzGerald O, Gladman DD, Gottlieb A, Helliwell PS, Husni ME, Love TJ, Lubrano E, McHugh N, Nash P, Ogdie A, Orbai AM, Parkinson A, O'Sullivan D, Rosen CF, Schwartzman S, Siegel EL, Toloza S, Tuong W, Ritchlin CT. Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recomendations for psoriatic arthritis. Arthritis Rheumatol. 2016; 68: 1060-1071. Go to original source... Go to PubMed...
  4. Neradilek F. Multidisciplinární řešení bolestí zad. Medicína po promoci 2006, 6: 71-78.
  5. Pavelka K. Bolest revmatických onemocnění, možnosti hodnocení a léčby. In: Rokyta a kol. Bolest. Tigis spol. s. r. o. Praha 2006: 425-444.
  6. Pavelka K. Doporučení české revmatologické společnosti pro léčbu ankylozující spondylitidy. Čes. Revmatol. 2012; 1: 4-19.
  7. Pavelka K, Vencovský J, Horák P, Šenolt L, Mann H, Štěpán J. Revmatologie. Maxdorf 2012.
  8. Pavelka K, Mann H. Zánětlivá bolest v zádech význam při screeningu a diagnostice spondyloartritid. Čes. Revmatol. 2014; 3: 143-152.
  9. Pavelka K, Vencovský J, Šenolt L, Horák P, Olejárová M, Tomčík M, Závada J, Štěpán J, a kolektiv. Farmakoterapie revmatických onemocnění. Maxdorf 2017.
  10. Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, S?rensen IJ, Ozgocmen S, Roussou E, Valle-O?ate R, Weber U, Wei J, Sieper J. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II). Validation and fial selection. Ann Rheum DIS 2009; 68: 777-783. Go to original source... Go to PubMed...
  11. Sieper J, van der Heijde D, Landewé R. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessemnt of SpondyloArthritis international Society (ASAS). Ann Rheum DIS 2009; 68: 784-788. Go to original source... Go to PubMed...
  12. Sieper J, Poddubnyy D. New evidence on the management of spondyloarthritis. Nat Rev Rheum Rheumatol 2016; 12: 282-295. Go to original source... Go to PubMed...
  13. Sheth T, Pitchumoni CS, Das KM. Management of musculoskeletal manifestations in inflammatory bowel disease. Gastroenterol Res Pract 2015; 2015: 387891. Go to original source...
  14. Šenolt L, Mann H. Axiální spondyloartritida. Practicus 2015; 4: 19-24.
  15. Šenolt L, Mann H, Herle P. Revmatologie - doporučení diagnostické a terapeutické postupy pro všeobecné praktické lékaře. Centrum doporučených postupů praktické lékaře 2014.
  16. Vrba I. Diferenciální diagnostika a léčba bolestí zad. Interní med 2008; 10(3): 142-145.
  17. van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Géher P, van der Horst-Bruinsma I, Inman DR, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Comp?n V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J. 2016 Update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 2017; 76: 978-992. Go to original source... Go to PubMed...
  18. Waddell G. The back pain revolution, second edition. Churchill Livingstone 2004: 9-459.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.